NCT06520631

Brief Summary

Kidney disease occurs when kidney reduces its normal function, less than 30% of normal activity is related to a long-term condition. Therefore, people need to participate in a haemodialysis (HD) programme. In HD, blood is filtered by an external machine, done about three times a week and the access is gained through intermittent vascular cannulation. The patients experience considerable pain due to the frequent insertion of AVF catheters. Hemodialysis patients experience anxiety before needle insertion due to repeated punctures, and over 90% of patients experience acute pain during the process. Puncture-related pain during arteriovenous fistula (AVF) cannulation in particular is a crucial influential factor in quality of life. Cryotherapy is one of the interventions used in several studies to alleviate the arteriovenous fistula puncture-related pain. It can be conduct by using ice packs and the results of the previous studies have also shown its positive effects on the relief of the fistula puncture-related pain in these patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 4, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 10, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 25, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 24, 2024

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

August 6, 2024

Status Verified

August 1, 2024

Enrollment Period

4 months

First QC Date

July 10, 2024

Last Update Submit

August 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual analogue scale (VAS):

    Scale to measure the intensity of pain The minimum value is 0 which means no pain and the maximum value is 10 which means the maximum pain

    Visual analogue scale measured at baseline, and it will be measured again immediately after 20 sessions

Secondary Outcomes (2)

  • The Arm Motor Ability Test (AMAT)

    The Arm Motor Ability Test (AMAT): it is measured at baseline, and it will be measured again immediately after 20 sessions.

  • Hospital Anxiety and Depression Scale (HADS):

    Hospital Anxiety and Depression Scale (HADS): it is measured at baseline, and it will be measured again immediately after 20 sessions.

Study Arms (2)

Cryotherapy to arteriovenous fistula puncture site

ACTIVE COMPARATOR

This group of patients receives ice pack applied on the site of the cannulation, for 20 sessions (3 sessions per week) it introduced for 5-10 minutes before the beginning of the dialysis.

Other: Ice packs (cryotherapy)

Cryotherapy to site opposite to arteriovenous fistula puncture site

ACTIVE COMPARATOR

This group of patients receives ice pack applied on contralateral to the site of the cannulation, for 20 sessions (3 sessions per week) it introduced for 5-10 minutes before the beginning of the dialysis.

Other: Ice packs (cryotherapy)

Interventions

One group of patients receives ice pack applied on the site of the cannulation, for 20 sessions (3 sessions per week) it introduced for 5-10 minutes before the beginning of the dialysis. The second group of patients receives ice pack applied on contralateral to the site of the cannulation, for 20 sessions (3 sessions per week) it introduced for 5-10 minutes before the beginning of the dialysis.

Cryotherapy to arteriovenous fistula puncture siteCryotherapy to site opposite to arteriovenous fistula puncture site

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The study includes patients with ages from 30 to 50 years.
  • Patients able to report pain adequately.
  • Patients with end-stage kidney failure undergoing regular hemodialysis who have been treated for more than 3 months, at least twice per week, with arteriovenous fistula in use for more than 1 month are included in the study.

You may not qualify if:

  • Patients with conditions such as
  • advanced age,
  • advanced diabetes,
  • cardiovascular insufficiency,
  • cold allergy,
  • Reynaud's phenomenon,
  • nerve and tissue damage,
  • fractures,
  • heart failure,
  • uncooperative patients,
  • cognitive impairment preventing a proper assessment of pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo university

Cairo, 11432, Egypt

RECRUITING

MeSH Terms

Interventions

Cryotherapy

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Nagwa Mohamed Badr, Professor

    Cairo University

    STUDY DIRECTOR
  • Sahier Omar El-khashab, Professor

    Cairo university El-kasr el-aini

    STUDY DIRECTOR

Central Study Contacts

Sara Fathy El-said, Physical therapist

CONTACT

Alaa Mohamed El-moatasem, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physical therapist

Study Record Dates

First Submitted

July 10, 2024

First Posted

July 25, 2024

Study Start

May 4, 2024

Primary Completion

August 24, 2024

Study Completion

August 31, 2024

Last Updated

August 6, 2024

Record last verified: 2024-08

Locations